Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect

Use of an anti-NGF antibody capable of inhibiting the binding between NGF and TrkA, capable of blocking the biological activity of TrkA for the preparation of a medicament for treating and/or preventing chronic pain.

Saved in:
Bibliographic Details
Main Authors Pavone Flaminia, Ugolini Gabriele, Cattaneo Antonino, Martinelli Sara
Format Patent
LanguageEnglish
Published 27.06.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Use of an anti-NGF antibody capable of inhibiting the binding between NGF and TrkA, capable of blocking the biological activity of TrkA for the preparation of a medicament for treating and/or preventing chronic pain.
Bibliography:Application Number: US20060921826